Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Blue light could help treat canine ear infections, study finds
Antibiotic resistance can make treating ear infections difficult.
Researchers found the treatment killed antibiotic-resistant bacteria.

A new study has suggested that blue light could be used to treat canine ear infections that aren't responding to antibiotics.

The researchers, from the University of Nottingham and the University of Birmingham, found that blue light could destroy antibiotic-resistant strains of the bacteria Pseudomonas aeruginosa.

The effectiveness of the treatment was even greater when combined with the antibiotic enrofloxacin.

Ear infections are one of the most common conditions seen in dogs. The condition affects up to 20 per cent of dogs globally. In 2016, it was the second most common diagnosis for dogs in the UK.

The researchers tested the effectiveness of using blue light as a treatment on six strains of P. aeruginosa isolated from dogs with otitis externa.

The light produces a chemical reaction within microbial cells, creating reactive oxygen species that can ultimately cause cell death. Different wavelengths of blue light were tested both alone and in combination with enrofloxacin.

The scientists found that some of the frequencies of blue light killed at least 99 per cent of the bacteria. The treatment reduced viable counts of Pseudomonas both with and without enrofloxacin, but the most effective results were achieved when used in combination with the antibiotic.

Following the success of the study, the researchers plan to test blue light treatment against a larger range of clinical Pseudomonas strains. Ultimately, they hope to be able to develop a simple method for using the treatment on dogs in clinics.

Robert Atterbury, associate professor in microbiology at the University of Nottingham, said: “Antibiotic resistance is a growing problem in both people and animals, including their pets. Pseudomonas ear infections in dogs are often very difficult to treat long-term because of this resistance.  
 
“The possibility of a new, non-invasive treatment for this condition, based on exposure to antimicrobial frequencies of blue light, has the potential to transform outcomes for pets and avoid the costly and difficult surgery which may ultimately be required otherwise.”

The study has been published in the journal Frontiers in Microbiology.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.